EN

GANG SHEN

教授

个人信息 更多+
  • 教师英文名称: SHEN GANG
  • 性别: 男
  • 在职信息: 在职
  • 所在单位: 软件学院
  • 学历: 研究生(博士)毕业

其他联系方式

暂无内容

论文成果

当前位置: 中文主页 - 科学研究 - 论文成果

Harnessing multiscale time–frequency ballistocardiography feature fusion for bedside atrial fibrillation detection

发布时间:2025-04-30
点击次数:
论文类型:
期刊论文
论文编号:
107885
发表刊物:
Biomedical Signal Processing and Control
收录刊物:
SCI
卷号:
108
关键字:
Atrial fibrillation Ballistocardiogram Temporal–spectral feature fusion Cross-band attention
DOI码:
10.1016/j.bspc.2025.107885
发表时间:
2025-04-29
影响因子:
4.9
摘要:
Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias worldwide and significantly increases the risk of ischemic stroke and heart failure, among other cardiovascular conditions. Given the serious health risks posed by atrial fibrillation, particularly in older adults, early screening is essential to prevent disease progression. The usually transient nature of early-stage atrial fibrillation makes continuous monitoring necessary. However, traditional diagnostic methods, such as Holter monitors, require strict operational standards and high levels of patient compliance, making extended home monitoring impractical. The unobtrusive data collection manner of ballistocardiogram (BCG) makes it a feasible option for long-term home cardiovascular health monitoring. However, the variability and diversity in ballistocardiogram data have obstructed its applications. In this study, we introduce FabosNet, a frequency-aware system designed for bedside overnight screening of atrial fibrillation using ballistocardiogram signals. By employing polyvinylidene fluoride (PVDF) film sensors placed on a mattress, our system allows for the unobtrusive collection of continuous ballistocardiogram data. Our classification algorithm leverages multiscale temporal–spectral feature fusion and cross-frequency band attention to detect atrial fibrillation from short segments of ballistocardiogram signals. Testing on a dataset of 70 subjects reveals that FabosNet achieves an accuracy between 95.26% and 96.78% for various segment lengths (5 to 30 s). Compared with other state-of-the-art methods, FabosNet effectively distinguishes between atrial fibrillation patients and those with occasional arrhythmias, highlighting its potential for early screening.